Health52 years ago
Pfizer breast cancer drug succeeds in mid-stage trial
Pfizer Inc’s experimental breast cancer drug significantly delayed progression of symptoms in a mid-stage trial, meeting the study’s primary goal and keeping Pfizer in the forefront...